Rheumatology Advance Access published online on January 6, 2006
Rheumatology, doi:10.1093/rheumatology/kei278
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Experimental Oncology I, IRCCS, Centro di Riferimento Oncologico, Aviano (PN), Italy
* To whom correspondence should be addressed. Objective. To identify and characterize rheumatoid factor (RF)-producing B-cells and cryoprecipitate immunoglobulin (Ig) M in hepatitis C virus (HCV)-positive patients. Methods. We purified and characterized, by peptide mass fingerprinting integrated with an NCBI IgBlast data bank search, the IgM component of cryoprecipitate and analysed the VDJ pattern of bone marrow B-cells by gene scan analysis of 17 HCV-positive patients with type II mixed-cryoglobulinaemia. Results. IgM purified from all of the patients presented an RF specificity. In three of these patients a high and predominant B-cell clone ( Conclusions. In the majority of mixed cryoglobulinaemia-HCV-positive patients, both in the serum and in B cells from the bone marrow, an oligoclonal pattern is the main molecular picture. When a monoclonal B-cell clone is found, its B-cell-receptor shows an antigen-binding fragment identical to that of cryoprecipitable RF-IgM. Phenotypically, B cells are CD20-positive but CD5-negative, suggesting that the B-1 B-cell subset is not likely to produce high-affinity IgM-RF molecules.
Received August 23, 2005
Accepted November 25, 2005
Original Papers
Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses
V. De Re 1 *,
S. De Vita 2,
D. Sansonno 3,
D. Gasparotto 1,
M. P. Simula 1,
F. A. Tucci 4,
A. Marzotto 1,
M. Fabris 2,
A. Gloghini 5,
A. Carbone 6,
F. Dammacco 3,
and
M. Boiocchi 1
2 Division of Rheumatology-DPMSC, University of Udine Medical School, Udine
3 Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari
4 Division of Experimental Oncology I, IRCCS, Centro di Riferimento Oncologico, Aviano (PN), Italy; Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari
5 Division of Pathology, IRCCS, Centro di Riferimento Oncologico, Aviano (PN), Italy
6 Division of Pathology, IRCCS, Centro di Riferimento Oncologico, Aviano (PN), Italy; Division of Pathology, IRCCS, Centro di Riferimento Oncologico, Aviano (PN), Italy
V. De Re, E-mail: vdere{at}cro.it
Abstract 
30%) was found in the bone marrow. B-cell-receptor sequences were determined and immunophenotyping of these clones was performed. Peptide masses originating after tryptic digestion of the B-cell-receptor combinatory regions and those originating by tryptic digestion of the cryoprecipitated IgM from the same patient were comparable. In the remaining patients an oligoclonal/polyclonality was found. However, in some of these patients we were able to find peptides that matched with the B-cell-receptor sequences of overexpanded B cells, indicating that, even in the absence of a clear monoclonal expansion, a fraction of total cryoprecipated IgM may derive from overexpanded B-cell clones found in patients’ bone marrow.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Quartuccio, M. Fabris, S. Salvin, M. Isola, F. Soldano, E. Falleti, C. A. Beltrami, V. De Re, and S. De Vita Bone marrow B-cell clonal expansion in type II mixed cryoglobulinaemia: association with nephritis Rheumatology, November 1, 2007; 46(11): 1657 - 1661. [Abstract] [Full Text] [PDF]
|
|